Novavax Inc.’s experimental Covid-19 vaccine showed immune response and protection against the highly contagious coronavirus variant originally identified in South Africa in a clinical trial.
Convalescent therapy has been touted as a fast, effective response to Covid-19, but a new therapy by GigaGen Inc. could be even more promising.
